The humble electrocardiogram

Practical Neurology

Volumn 8, Issue 1, 2008, Pages 46-59

  Marsh, Eleanor ^a   O'Callaghan, Peter ^a   Smith, Philip E M ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; PHENYTOIN; VASODILATOR AGENT; VERAPAMIL;

BRAIN DISEASE; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART; HEART ARRHYTHMIA; HUMAN; METHODOLOGY; NEUROLOGIC DISEASE; NEUROLOGY; REVIEW; UNCONSCIOUSNESS;

ANTICONVULSANTS; ARRHYTHMIAS, CARDIAC; BRAIN DISEASES; ELECTROCARDIOGRAPHY; HEART; HUMANS; NERVOUS SYSTEM DISEASES; NEUROLOGY; PHENYTOIN; UNCONSCIOUSNESS; VASODILATOR AGENTS; VERAPAMIL;

EID: 39049146959     PISSN: 14747758     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2007.140988     Document Type: Review

References (38)

1. Argyle B. MicroEKG Computer program Manual. Alpine, Utah: Mad Scientist Software, 2000.
2. Kapoor WN. Evaluation and outcome of patients with syncope. Medicine (Baltimore) 1990;69:160-5.
3. Sarasin FP, Junod AF, Carballo D, et al. Role of echocardiography in the evaluation of syncope: a prospective study. Heart 2002; 88:363-7.
4. AVID: The Antiarrhythmics Versus Implantable Defibrillators Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
5. Pinto DS, Josephson ME. Sudden cardiac death. In Fuster V, Alexander RW, O'Rourke RA, eds. Hurst's the heart. Tenth edition. McGraw-Hill, 2001:1015-48.
6. Thiene G, Nava A, Corrado D, et al. Right ventricula cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-33.
7. Hamid MS, Norman M, Quraish A, et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002;40:1445-50.
8. Sen-Chowdhry S, Lowe MD, Sporton SC, et al. Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. Am J Med 2004;117:685-91.
9. Romano C. Congenital cardiac arrhythmia. Lancet 1965; 1:658-9.
10. Paydak H, Telfer A, Kehoe R, et al. Brugada syndrome-an unusual cause of convulsive syncope. Arch Intern Med 2002; 162:1416-19.
11. Garson A, Dick M, Fournier A, et al. The long QT syndrome in children: an international study of 287 patients. Circulation 1993;87:1866-72.
12. Van Mieghem C, Sabbe M, Knockaert D. The clinical value of the ECG in noncardiac conditions. Chest 2004;125:1561-73.
13. ArizonaCERT (University of Arizona Health Sciences Center). Available at http://www.torsades.org (accessed 13 December 2006).
14. Alings M, Wilde A. Brugada syndrome: clinical data and suggested pathophysiological mechanism. Circulation 1999;99:666-73.
15. Blumhardt LD, Smith PEM, Owen L Electrocardiographic accompaniments of temporal lobe epileptic seizures. Lancet 1986;1:1051-5.
16. Rugg-Gunn FJ, Simister RJ, Squirrell M, et al. Cardiac arrhythmias in focal epilepsy: a prospective long-term study. Lancet 2004; 364:2212-19.
17. Kitching AD, Bernstein M. Primary intracranial haemorrhage presenting as acute myocardial infarction: a contra indication to thrombolytic therapy. CMAJ 1994;150:519-22.
18. Kumar R, Fisher M. Neurogenic T waves after subdural haematoma. Hosp Med 2004;65:306-7.
19. Korpelainen JT, Huikuri HV, Sotaniemi KA, et al. Abnormal heart rate variability reflecting autonomic dysfunction in brainstem infarction. Acta Neural Scand 1996;94:337-42.
20. Yu Gurevich T, Groozman GB, Givadi N, et al. R-R interval variation in Parkinson's disease and multiple system atrophy. Acta Neurol Scand 2004;109:276-9.
21. Flachenecker P, Toyka KV, Reiners K. Cardiac arrhythmias in Guillain-Barré syndrome. An overview of the diagnosis of a rare but potentially life-threatening complication. Nervenaarzt 2001; 72:610-17.
22. Taylor AJ, Wortham DC, Burge JR, et al. The heart in polymyositis: a prospective evaluation of 26 patients. Clin Cardiol 1993; 16:802-8.
23. Lundberg IE. Cardiac involvement in autoimmune myositis and mixed connective tissue disease. Lupus 2005;14:708-12.
24. Alyan O, Ozdemir O, Geyik B, et al. Polymyositis complicated with complete atrioventricular block-a case report and review of the literature. Angiology 2003;54:729-31.
25. Pelargonio G, Russo AD, Sanna T, et al. Myotonic dystrophy and the heart. Heart 2002;88:665-70.
26. Church S. The heart in myotonica atrophica. Arch Intern Med 1967;119:176-81.
27. Sabovic M, Medica I, Logar N, et al. Relation of CTG expansion and clinical variables to electrocardiogram conduction abnormalities and sudden death in patients with myotonic dystrophy. Neuromusc Dis 2003;13:822-6.
28. Cox GF, Kunkel LM. Dystrophies and heart disease. Curr Op Cardiol 1997;12:329-43.
29. Munoz J, Sunjuan R, Morell JS, et al. Ventricular tachycardia in Duchenne's muscular dystrophy. Int J Cardiol 1996; 54:259-62.
30. Slucka C. The electrocardiogram in Duchenne progressive muscular dystrophy. Circulation 1966;38:933-40.
31. Sanna T, Della Russo A, Toniolo D, et al. Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations. Eur Heart J 2003;24:2227-36.
32. Graves TD, Hanna MG. Neurological channelopathies. Postgrad Med J 2005;81:20-32.
33. Campuzano V, Montermini L, Malta MD, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion Science 1996;271:1423-7.
34. Clark DS, Myerburg RG, Morales A, et al. Heart block in Kearns-Sayre syndrome: electrophysiologic-pathologic correlation. Chest 1975;68:727-30.
35. Anan R, Nakagawq M, Miyata M, et al. Cardiac involvement in mitochondrial diseases: a study of 17 patients with documented mitochondrial DNA defects. Circulation 1995;91:955-61.
36. Sorajja P, Sweeney MG, Chalmers R, et al. Cardiac abnormalities in patients with Leber's hereditary optic neuropathy. Heart 2003; 89:791-2.
37. Mehta J, Tuna N, Moller JH, et al. Electrocardiographic and vectorcardiographic abnormalities in Fabry's disease. Am Heart J 1977;93:699-705.
38. Sugie K, Yamamoto A, Murayama K, et al. Clinicopathological features of genetically confirmed Danon disease. Neurology 2002; 58:1773-8.